Ferring to Present Analyses of Data for REBYOTA (fecal microbiota, live - jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, at DDW 2023
In: Contify Life Science News, 2023-04-18, S. 4
Zeitungsartikel
Zugriff:
Titel: |
Ferring to Present Analyses of Data for REBYOTA (fecal microbiota, live - jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, at DDW 2023
|
---|---|
Link: | |
Zeitschrift: | Contify Life Science News, 2023-04-18, S. 4 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|